Global Amlodipine Besylate Market Research Report 2021

Global Amlodipine Besylate Market Research Report 2021

Table of Contents
1 Amlodipine Besylate Market Overview
1.1 Product Overview and Scope of Amlodipine Besylate
1.2 Amlodipine Besylate Segment by Type
1.2.1 Global Amlodipine Besylate Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Amlodipine Besylate Segment by Application
1.3.1 Amlodipine Besylate Sales Comparison by Application: (2021-2027)
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Global Amlodipine Besylate Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Besylate Revenue 2016-2027
1.4.2 Global Amlodipine Besylate Sales 2016-2027
1.4.3 Amlodipine Besylate Market Size by Region: 2016 Versus 2021 Versus 2027
2 Amlodipine Besylate Market Competition by Manufacturers
2.1 Global Amlodipine Besylate Sales Market Share by Manufacturers (2016-2021)
2.2 Global Amlodipine Besylate Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Amlodipine Besylate Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Amlodipine Besylate Manufacturing Sites, Area Served, Product Type
2.5 Amlodipine Besylate Market Competitive Situation and Trends
2.5.1 Amlodipine Besylate Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Amlodipine Besylate Players Market Share by Revenue
2.5.3 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amlodipine Besylate Retrospective Market Scenario by Region
3.1 Global Amlodipine Besylate Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Amlodipine Besylate Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Amlodipine Besylate Market Facts & Figures by Country
3.3.1 North America Amlodipine Besylate Sales by Country
3.3.2 North America Amlodipine Besylate Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Amlodipine Besylate Market Facts & Figures by Country
3.4.1 Europe Amlodipine Besylate Sales by Country
3.4.2 Europe Amlodipine Besylate Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Amlodipine Besylate Market Facts & Figures by Region
3.5.1 Asia Pacific Amlodipine Besylate Sales by Region
3.5.2 Asia Pacific Amlodipine Besylate Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Amlodipine Besylate Market Facts & Figures by Country
3.6.1 Latin America Amlodipine Besylate Sales by Country
3.6.2 Latin America Amlodipine Besylate Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
3.7.1 Middle East and Africa Amlodipine Besylate Sales by Country
3.7.2 Middle East and Africa Amlodipine Besylate Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Amlodipine Besylate Historic Market Analysis by Type
4.1 Global Amlodipine Besylate Sales Market Share by Type (2016-2021)
4.2 Global Amlodipine Besylate Revenue Market Share by Type (2016-2021)
4.3 Global Amlodipine Besylate Price by Type (2016-2021)
5 Global Amlodipine Besylate Historic Market Analysis by Application
5.1 Global Amlodipine Besylate Sales Market Share by Application (2016-2021)
5.2 Global Amlodipine Besylate Revenue Market Share by Application (2016-2021)
5.3 Global Amlodipine Besylate Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Mylan Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Dr. Reddy's Laboratories Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Apotex Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Pharmaceutical Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Cipla Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hikma Pharmaceuticals Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Strides Pharma
6.8.1 Strides Pharma Corporation Information
6.8.2 Strides Pharma Description and Business Overview
6.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Strides Pharma Product Portfolio
6.8.5 Strides Pharma Recent Developments/Updates
6.9 Upsher-Smith Laboratories
6.9.1 Upsher-Smith Laboratories Corporation Information
6.9.2 Upsher-Smith Laboratories Description and Business Overview
6.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Upsher-Smith Laboratories Product Portfolio
6.9.5 Upsher-Smith Laboratories Recent Developments/Updates
6.10 InvaGen Pharmaceuticals
6.10.1 InvaGen Pharmaceuticals Corporation Information
6.10.2 InvaGen Pharmaceuticals Description and Business Overview
6.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.10.4 InvaGen Pharmaceuticals Product Portfolio
6.10.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Amlodipine Besylate Description and Business Overview
6.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sun Pharmaceutical Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Amlodipine Besylate Description and Business Overview
6.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Aurobindo Pharma Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Lupin Pharmaceuticals
6.13.1 Lupin Pharmaceuticals Corporation Information
6.13.2 Lupin Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Lupin Pharmaceuticals Product Portfolio
6.13.5 Lupin Pharmaceuticals Recent Developments/Updates
6.14 Zydus Pharmaceuticals
6.14.1 Zydus Pharmaceuticals Corporation Information
6.14.2 Zydus Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Zydus Pharmaceuticals Product Portfolio
6.14.5 Zydus Pharmaceuticals Recent Developments/Updates
6.15 Oxford Pharm
6.15.1 Oxford Pharm Corporation Information
6.15.2 Oxford Pharm Amlodipine Besylate Description and Business Overview
6.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Oxford Pharm Product Portfolio
6.15.5 Oxford Pharm Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Amlodipine Besylate Description and Business Overview
6.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Wockhardt Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Epic Pharma
6.17.1 Epic Pharma Corporation Information
6.17.2 Epic Pharma Amlodipine Besylate Description and Business Overview
6.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Epic Pharma Product Portfolio
6.17.5 Epic Pharma Recent Developments/Updates
6.18 CR Pharmaceutical
6.18.1 CR Pharmaceutical Corporation Information
6.18.2 CR Pharmaceutical Amlodipine Besylate Description and Business Overview
6.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.18.4 CR Pharmaceutical Product Portfolio
6.18.5 CR Pharmaceutical Recent Developments/Updates
6.19 Alkem Laboratories
6.19.1 Alkem Laboratories Corporation Information
6.19.2 Alkem Laboratories Amlodipine Besylate Description and Business Overview
6.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Alkem Laboratories Product Portfolio
6.19.5 Alkem Laboratories Recent Developments/Updates
6.20 MACLEODS
6.20.1 MACLEODS Corporation Information
6.20.2 MACLEODS Amlodipine Besylate Description and Business Overview
6.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
6.20.4 MACLEODS Product Portfolio
6.20.5 MACLEODS Recent Developments/Updates
7 Amlodipine Besylate Manufacturing Cost Analysis
7.1 Amlodipine Besylate Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Amlodipine Besylate
7.4 Amlodipine Besylate Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Amlodipine Besylate Distributors List
8.3 Amlodipine Besylate Customers
9 Amlodipine Besylate Market Dynamics
9.1 Amlodipine Besylate Industry Trends
9.2 Amlodipine Besylate Growth Drivers
9.3 Amlodipine Besylate Market Challenges
9.4 Amlodipine Besylate Market Restraints
10 Global Market Forecast
10.1 Amlodipine Besylate Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Amlodipine Besylate by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Amlodipine Besylate by Type (2022-2027)
10.2 Amlodipine Besylate Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Amlodipine Besylate by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Amlodipine Besylate by Application (2022-2027)
10.3 Amlodipine Besylate Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Amlodipine Besylate by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Amlodipine Besylate by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Amlodipine Besylate Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Amlodipine Besylate Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Amlodipine Besylate Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Amlodipine Besylate Covered in This Study
Table 5. Global Amlodipine Besylate Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Amlodipine Besylate Sales Share by Manufacturers (2016-2021)
Table 7. Global Amlodipine Besylate Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Amlodipine Besylate Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Amlodipine Besylate Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Amlodipine Besylate Manufacturing Sites and Area Served
Table 11. Manufacturers Amlodipine Besylate Product Type
Table 12. Global Amlodipine Besylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amlodipine Besylate as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Amlodipine Besylate Sales by Region (2016-2021) & (K Units)
Table 16. Global Amlodipine Besylate Sales Market Share by Region (2016-2021)
Table 17. Global Amlodipine Besylate Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Amlodipine Besylate Sales by Country (2016-2021) & (K Units)
Table 19. North America Amlodipine Besylate Sales Market Share by Country (2016-2021)
Table 20. North America Amlodipine Besylate Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Amlodipine Besylate Revenue Market Share by Country (2016-2021)
Table 22. Europe Amlodipine Besylate Sales by Country (2016-2021) & (K Units)
Table 23. Europe Amlodipine Besylate Sales Market Share by Country (2016-2021)
Table 24. Europe Amlodipine Besylate Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Amlodipine Besylate Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Amlodipine Besylate Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Amlodipine Besylate Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Amlodipine Besylate Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Amlodipine Besylate Revenue Market Share by Region (2016-2021)
Table 30. Latin America Amlodipine Besylate Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Amlodipine Besylate Sales Market Share by Country (2016-2021)
Table 32. Latin America Amlodipine Besylate Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Amlodipine Besylate Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Amlodipine Besylate Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Amlodipine Besylate Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Amlodipine Besylate Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Amlodipine Besylate Revenue Market Share by Country (2016-2021)
Table 38. Global Amlodipine Besylate Sales (K Units) by Type (2016-2021)
Table 39. Global Amlodipine Besylate Sales Market Share by Type (2016-2021)
Table 40. Global Amlodipine Besylate Revenue (Million US$) by Type (2016-2021)
Table 41. Global Amlodipine Besylate Revenue Share by Type (2016-2021)
Table 42. Global Amlodipine Besylate Price (USD/Unit) by Type (2016-2021)
Table 43. Global Amlodipine Besylate Sales (K Units) by Application (2016-2021)
Table 44. Global Amlodipine Besylate Sales Market Share by Application (2016-2021)
Table 45. Global Amlodipine Besylate Revenue (Million US$) by Application (2016-2021)
Table 46. Global Amlodipine Besylate Revenue Share by Application (2016-2021)
Table 47. Global Amlodipine Besylate Price (USD/Unit) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Amlodipine Besylate Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Mylan Corporation Information
Table 54. Mylan Description and Business Overview
Table 55. Mylan Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Mylan Amlodipine Besylate Product
Table 57. Mylan Recent Developments/Updates
Table 58. Dr. Reddy's Laboratories Corporation Information
Table 59. Dr. Reddy's Laboratories Description and Business Overview
Table 60. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Dr. Reddy's Laboratories Amlodipine Besylate Product
Table 62. Dr. Reddy's Laboratories Recent Developments/Updates
Table 63. Apotex Corporation Information
Table 64. Apotex Description and Business Overview
Table 65. Apotex Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Apotex Amlodipine Besylate Product
Table 67. Apotex Recent Developments/Updates
Table 68. Teva Pharmaceutical Corporation Information
Table 69. Teva Pharmaceutical Description and Business Overview
Table 70. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Teva Pharmaceutical Amlodipine Besylate Product
Table 72. Teva Pharmaceutical Recent Developments/Updates
Table 73. Cipla Corporation Information
Table 74. Cipla Description and Business Overview
Table 75. Cipla Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Cipla Amlodipine Besylate Product
Table 77. Cipla Recent Developments/Updates
Table 78. Hikma Pharmaceuticals Corporation Information
Table 79. Hikma Pharmaceuticals Description and Business Overview
Table 80. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Hikma Pharmaceuticals Amlodipine Besylate Product
Table 82. Hikma Pharmaceuticals Recent Developments/Updates
Table 83. Strides Pharma Corporation Information
Table 84. Strides Pharma Description and Business Overview
Table 85. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Strides Pharma Amlodipine Besylate Product
Table 87. Strides Pharma Recent Developments/Updates
Table 88. Upsher-Smith Laboratories Corporation Information
Table 89. Upsher-Smith Laboratories Description and Business Overview
Table 90. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Upsher-Smith Laboratories Amlodipine Besylate Product
Table 92. Upsher-Smith Laboratories Recent Developments/Updates
Table 93. InvaGen Pharmaceuticals Corporation Information
Table 94. InvaGen Pharmaceuticals Description and Business Overview
Table 95. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. InvaGen Pharmaceuticals Amlodipine Besylate Product
Table 97. InvaGen Pharmaceuticals Recent Developments/Updates
Table 98. Sun Pharmaceutical Corporation Information
Table 99. Sun Pharmaceutical Description and Business Overview
Table 100. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Sun Pharmaceutical Amlodipine Besylate Product
Table 102. Sun Pharmaceutical Recent Developments/Updates
Table 103. Aurobindo Pharma Corporation Information
Table 104. Aurobindo Pharma Description and Business Overview
Table 105. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Aurobindo Pharma Amlodipine Besylate Product
Table 107. Aurobindo Pharma Recent Developments/Updates
Table 108. Lupin Pharmaceuticals Corporation Information
Table 109. Lupin Pharmaceuticals Description and Business Overview
Table 110. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Lupin Pharmaceuticals Amlodipine Besylate Product
Table 112. Lupin Pharmaceuticals Recent Developments/Updates
Table 113. Zydus Pharmaceuticals Corporation Information
Table 114. Zydus Pharmaceuticals Description and Business Overview
Table 115. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Zydus Pharmaceuticals Amlodipine Besylate Product
Table 117. Zydus Pharmaceuticals Recent Developments/Updates
Table 118. Oxford Pharm Corporation Information
Table 119. Oxford Pharm Description and Business Overview
Table 120. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Oxford Pharm Amlodipine Besylate Product
Table 122. Oxford Pharm Recent Developments/Updates
Table 123. Wockhardt Corporation Information
Table 124. Wockhardt Description and Business Overview
Table 125. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Wockhardt Amlodipine Besylate Product
Table 127. Wockhardt Recent Developments/Updates
Table 128. Epic Pharma Corporation Information
Table 129. Epic Pharma Description and Business Overview
Table 130. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Epic Pharma Amlodipine Besylate Product
Table 132. Epic Pharma Recent Developments/Updates
Table 133. CR Pharmaceutical Corporation Information
Table 134. CR Pharmaceutical Description and Business Overview
Table 135. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. CR Pharmaceutical Amlodipine Besylate Product
Table 137. CR Pharmaceutical Recent Developments/Updates
Table 138. Alkem Laboratories Corporation Information
Table 139. Alkem Laboratories Description and Business Overview
Table 140. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Alkem Laboratories Amlodipine Besylate Product
Table 142. Alkem Laboratories Recent Developments/Updates
Table 143. MACLEODS Corporation Information
Table 144. MACLEODS Description and Business Overview
Table 145. MACLEODS Amlodipine Besylate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. MACLEODS Amlodipine Besylate Product
Table 147. MACLEODS Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Amlodipine Besylate Distributors List
Table 151. Amlodipine Besylate Customers List
Table 152. Amlodipine Besylate Market Trends
Table 153. Amlodipine Besylate Growth Drivers
Table 154. Amlodipine Besylate Market Restraints
Table 155. Global Amlodipine Besylate Sales Forecast by Type (2022-2027) & (K Units)
Table 156. Global Amlodipine Besylate Sales Market Share Forecast by Type (2022-2027)
Table 157. Global Amlodipine Besylate Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 158. Global Amlodipine Besylate Revenue Market Share Forecast by Type (2022-2027)
Table 159. Global Amlodipine Besylate Sales Forecast by Application (2022-2027) & (K Units)
Table 160. Global Amlodipine Besylate Sales Market Share Forecast by Application (2022-2027)
Table 161. Global Amlodipine Besylate Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 162. Global Amlodipine Besylate Revenue Market Share Forecast by Application (2022-2027)
Table 163. Global Amlodipine Besylate Sales Forecast by Region (2022-2027) & (K Units)
Table 164. Global Amlodipine Besylate Sales Market Share Forecast by Region (2022-2027)
Table 165. Global Amlodipine Besylate Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 166. Global Amlodipine Besylate Revenue Market Share Forecast by Region (2022-2027)
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amlodipine Besylate
Figure 2. Global Amlodipine Besylate Market Share by Type in 2020 & 2027
Figure 3. 2.5mg Tablets Product Picture
Figure 4. 5mg Tablets Product Picture
Figure 5. 10mg Tablets Product Picture
Figure 6. Global Amlodipine Besylate Market Share by Application in 2020 & 2027
Figure 7. High Blood Pressure
Figure 8. Heart Disease
Figure 9. Global Amlodipine Besylate Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Amlodipine Besylate Market Size 2016-2027 (US$ Million)
Figure 11. Global Amlodipine Besylate Sales 2016-2027 (K Units)
Figure 12. Global Amlodipine Besylate Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Amlodipine Besylate Sales Share by Manufacturers in 2020
Figure 14. Global Amlodipine Besylate Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Amlodipine Besylate Players: Market Share by Revenue in 2020
Figure 16. Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Amlodipine Besylate Sales Market Share by Region (2016-2021)
Figure 18. Global Amlodipine Besylate Sales Market Share by Region in 2020
Figure 19. Global Amlodipine Besylate Revenue Market Share by Region (2016-2021)
Figure 20. Global Amlodipine Besylate Revenue Market Share by Region in 2020
Figure 21. U.S. Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Amlodipine Besylate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Amlodipine Besylate by Type (2016-2021)
Figure 46. Sales Market Share of Amlodipine Besylate by Application (2016-2021)
Figure 47. Sales Market Share of Amlodipine Besylate by Application in 2020
Figure 48. Revenue Share of Amlodipine Besylate by Application (2016-2021)
Figure 49. Revenue Share of Amlodipine Besylate by Application in 2020
Figure 50. Manufacturing Cost Structure of Amlodipine Besylate
Figure 51. Manufacturing Process Analysis of Amlodipine Besylate
Figure 52. Amlodipine Besylate Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs